ChordNews
← All news

Autolus expects 2026 AUCATZYL net product revenue of at least $150M and shifts BOBCAT data to October 2027

By ChordNews · First written

Comments 0

Summary

Autolus expects full-year 2026 net product revenue for AUCATZYL of at or above $150 million, and the timing of BOBCAT data has moved to October 2027, according to a Seeking Alpha breaking-news headline. The supplied item is headline-only, with no article body, so no further detail is available.

This continues an earlier story: Akamai anticipates CIS revenue of $1.1B-$1.3B in 2027 as Anthropic deal timing shifts $30M into 2027

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Autolus expects full-year 2026 AUCATZYL net product revenue at or above $150M, as BOBCAT data shifts to October 2027.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews